- Showing:
- All Topics
News | News
News | News
China: Emergency use approval granted to CanSino’s inhaled vaccine for Covid-19 - LifeSci Voice
The newly developed Covid vaccine by China’s CanSino Biologics Inc has been given the green light by the nation’s drug regulating authority to be used as a booster in emergency cases. In a filing on Sunday, CanSino stated that their inhaled form
News | News
Guardant and Merck KGaA collaborate for cancer solution - LifeSci Voice
In order to strengthen the development of precision oncology treatments, Guardant Health has partnered with Merck KGaA. The two companies have a history of a partnership, extending back to 2017, for the purpose of developing a liquid biopsy panel which wo
News | News
Boehringer Ingelheim receives its first dermatology approval from FDA - LifeSci Voice
Boehringer Ingelheim has received its first dermatology approval from FDA, becoming the first company to do so for the treatment of generalised pustular psoriasis. Boehringer Ingelheim’s (BI) drug Spevigo has recently gained FDA approval for treatment o
News | News
European Commission Approved Bavarian Nordic’s Smallpox Vaccine
European Commission (EC) has approved Imvanex, the smallpox vaccine from Bavarian Nordic. The drug can also be used against monkeypox.
News | News
Novratis and BeiGene’s PD-1 drug falls victim to FDA approval delay - LifeSci Voice
The FDA has delayed the approval decision for Novratis and BeiGene’s tislelizumab. The inspections were supposed to take place in China.
